BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15091198)

  • 1. Temozolomide as prophylaxis for melanoma brain metastases.
    Conill C; González-Cao M; Jorcano S; Puig S; Malvehy J; Martí R; Castel T
    Melanoma Res; 2004 Feb; 14(1):73-4. PubMed ID: 15091198
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of brain metastases of malignant melanoma with temozolomide.
    Biasco G; Pantaleo MA; Casadei S
    N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete response of multiple melanoma brain metastases after treatment with temozolomide.
    Dvorak J; Melichar B; Zizka J; Hadzi-Nikolov D; Petera J
    Onkologie; 2004 Apr; 27(2):171-4. PubMed ID: 15138351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide for advanced, metastatic melanoma.
    Cohen MH; Johnson JR; Middleton MR
    J Clin Oncol; 2000 May; 18(10):2185. PubMed ID: 10811684
    [No Abstract]   [Full Text] [Related]  

  • 5. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
    Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
    J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.
    Hofmann M; Kiecker F; Wurm R; Schlenger L; Budach V; Sterry W; Trefzer U
    J Neurooncol; 2006 Jan; 76(1):59-64. PubMed ID: 16132502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide].
    Conill C; Puig S; Toscas I; Castel T
    Med Clin (Barc); 2002 Nov; 119(19):758-9. PubMed ID: 12487980
    [No Abstract]   [Full Text] [Related]  

  • 8. Temozolomide for Treating Malignant Melanoma.
    Li RH; Hou XY; Yang CS; Liu WL; Tang JQ; Liu YQ; Jiang G
    J Coll Physicians Surg Pak; 2015 Sep; 25(9):680-8. PubMed ID: 26374366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study.
    Schadendorf D; Hauschild A; Ugurel S; Thoelke A; Egberts F; Kreissig M; Linse R; Trefzer U; Vogt T; Tilgen W; Mohr P; Garbe C
    Ann Oncol; 2006 Oct; 17(10):1592-7. PubMed ID: 17005632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
    Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
    Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma.
    Agarwala SS; Kirkwood JM
    Oncologist; 2000; 5(2):144-51. PubMed ID: 10794805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life, at what cost?
    Oubre DN
    Cancer Invest; 2003; 21(6):965-6. PubMed ID: 14735700
    [No Abstract]   [Full Text] [Related]  

  • 13. Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine.
    Kiebert GM; Jonas DL; Middleton MR
    Cancer Invest; 2003; 21(6):821-9. PubMed ID: 14735685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma.
    Treudler R; Georgieva J; Geilen CC; Orfanos CE
    J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide.
    Koekkoek JA; Wiggenraad RG; Zwinkels H; Oosterkamp HM; Taphoorn MJ
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23008380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].
    Conill C; Fernández-Ibiza J; Malvehy J; Puig S; Sánchez M; Castel T
    Med Clin (Barc); 2004 Mar; 122(11):413-5. PubMed ID: 15066248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma: a meta-analysis consisting of 1314 patients.
    Teimouri F; Nikfar S; Abdollahi M
    Melanoma Res; 2013 Oct; 23(5):381-9. PubMed ID: 23880781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?
    Boogerd W; de Gast GC; Dalesio O
    Cancer; 2007 Jan; 109(2):306-12. PubMed ID: 17149755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
    Gogas H; Polyzos A; Stavrinidis I; Frangia K; Tsoutsos D; Panagiotou P; Markopoulos C; Papadopoulos O; Pectasides D; Mantzourani M; Middleton M; Vaiopoulos G; Fountzilas G
    Ann Oncol; 2006 Dec; 17(12):1835-41. PubMed ID: 16980601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case of melanoma recurring as subcutaneous metastatic melanoma with overlying ecchymoses.
    Dehart WK; Gilliam AC; Lu KQ; Brell J
    Arch Dermatol; 2008 Apr; 144(4):561-2. PubMed ID: 18427064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.